ADMA Biologics' Q2 earnings and revenue beat can be attributed to Asceniv growth. However, shares fall 7.4% in after-hours trading.

Over 1,100 colleges risk losing federal aid as student loan defaults surge. Learn how this impacts schools and forces future ...